Pretreatment PSA levels affects the completion rate of Ra-223 treatment

The aim of this study was to review our initial experience of using radium 223 (Ra-223) for metastatic castration-resistant prostate cancer (CRPC) and to evaluate whether pretreatment PSA levels correlate with completion of Ra-223 treatment. In addition, we examined change ratios of PSA, ALP and BAP...

Descripción completa

Detalles Bibliográficos
Autores principales: Utsumi, Nobuko, Kurosaki, Hiromasa, Miura, Kosei, Kitoh, Hiroki, Akakura, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979791/
https://www.ncbi.nlm.nih.gov/pubmed/33742050
http://dx.doi.org/10.1038/s41598-021-86033-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979791/
https://www.ncbi.nlm.nih.gov/pubmed/33742050
http://dx.doi.org/10.1038/s41598-021-86033-4

Ejemplares similares